Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry
Background We have evaluated the ex vivo pharmacology of single drugs and drug combinations in malignant cells of bone marrow samples from 125 patients with acute myeloid leukemia using a novel automated flow cytometry-based platform (ExviTech). We have improved previous ex vivo drug testing with 4...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2014 |
| País: | España |
| Institución: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:ddd.uab.cat:301838 |
| Acceso en línea: | https://ddd.uab.cat/record/301838 https://dx.doi.org/urn:doi:10.1016/j.clml.2013.11.006 |
| Access Level: | acceso abierto |
| Palabra clave: | Chemosensitivity Ex vivo Flow cytometry Individualized tumor response to testing Personalized medicine |
| id |
ES_8966cb651707cf3de00a34b782263ac5 |
|---|---|
| oai_identifier_str |
oai:ddd.uab.cat:301838 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometryA bridge to individualized medicineBennett, Teresa A.Montesinos, Pau|||0000-0002-3275-5593Moscardo, FedericoMartinez-Cuadron, DavidMartinez, JoaquinSierra, Jorge|||0000-0002-7966-0356García, RaimundoPerez de Oteyza, Jaime|||0000-0002-8338-2037Fernandez, PascualSerrano, JosefinaFernandez, AngelesHerrera, Pilar|||0000-0002-4118-7110Gonzalez, AtaulfoBethancourt, ConcepciónRodriguez-Macias, GabrielaAlonso, AranchaVera, Juan A.Navas Elorza, BegonaLavilla, Esperanza|||0000-0003-1490-0678López, Juan A.Jiménez, SantiagoSimiele, AdrianaVidriales, BelenGonzález, Bernardo J.Burgaleta, CarmenHernández Rivas, José A.Córdoba Mascuñano, RaúlBautista, GuiomarPerez Simon, José A.De la Fuente, AdolfoRayón, ConsolaciónTroconiz, Iñaki|||0000-0003-3700-8658Janda, ÁlvaroBosanquet, Andrew G.Hernández-Campo, PilarPrimo, DanielLópez, RocíoLiébana, BelenRojas, José L.Gorrochategui, Julián|||0000-0001-9262-8716Sanz, Miguel A.|||0000-0003-1489-1177Ballesteros, JoanChemosensitivityEx vivoFlow cytometryIndividualized tumor response to testingPersonalized medicineBackground We have evaluated the ex vivo pharmacology of single drugs and drug combinations in malignant cells of bone marrow samples from 125 patients with acute myeloid leukemia using a novel automated flow cytometry-based platform (ExviTech). We have improved previous ex vivo drug testing with 4 innovations: identifying individual leukemic cells, using intact whole blood during the incubation, using an automated platform that escalates reliably data, and performing analyses pharmacodynamic population models. Patients and Methods Samples were sent from 24 hospitals to a central laboratory and incubated for 48 hours in whole blood, after which drug activity was measured in terms of depletion of leukemic cells. Results The sensitivity of single drugs is assessed for standard efficacy (E) and potency (EC) variables, ranked as percentiles within the population. The sensitivity of drug-combination treatments is assessed for the synergism achieved in each patient sample. We found a large variability among patient samples in the dose-response curves to a single drug or combination treatment. Conclusion We hypothesize that the use of the individual patient ex vivo pharmacological profiles may help to guide a personalized treatment selection. © 2014 The Authors. Published by Elsevier Inc. All rights reserved.Universitat Autònoma de Barcelona. Departament de Medicina 22014-01-0120142014-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/301838https://dx.doi.org/urn:doi:10.1016/j.clml.2013.11.006reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra, i la creació d'obres derivades, sempre que no sigui amb finalitats comercials i que es distribueixin sota la mateixa llicència que regula l'obra original. Cal que es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by-nc-sa/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3018382026-06-06T12:50:31Z |
| dc.title.none.fl_str_mv |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry A bridge to individualized medicine |
| title |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| spellingShingle |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry Bennett, Teresa A. Chemosensitivity Ex vivo Flow cytometry Individualized tumor response to testing Personalized medicine |
| title_short |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| title_full |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| title_fullStr |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| title_full_unstemmed |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| title_sort |
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry |
| dc.creator.none.fl_str_mv |
Bennett, Teresa A. Montesinos, Pau|||0000-0002-3275-5593 Moscardo, Federico Martinez-Cuadron, David Martinez, Joaquin Sierra, Jorge|||0000-0002-7966-0356 García, Raimundo Perez de Oteyza, Jaime|||0000-0002-8338-2037 Fernandez, Pascual Serrano, Josefina Fernandez, Angeles Herrera, Pilar|||0000-0002-4118-7110 Gonzalez, Ataulfo Bethancourt, Concepción Rodriguez-Macias, Gabriela Alonso, Arancha Vera, Juan A. Navas Elorza, Begona Lavilla, Esperanza|||0000-0003-1490-0678 López, Juan A. Jiménez, Santiago Simiele, Adriana Vidriales, Belen González, Bernardo J. Burgaleta, Carmen Hernández Rivas, José A. Córdoba Mascuñano, Raúl Bautista, Guiomar Perez Simon, José A. De la Fuente, Adolfo Rayón, Consolación Troconiz, Iñaki|||0000-0003-3700-8658 Janda, Álvaro Bosanquet, Andrew G. Hernández-Campo, Pilar Primo, Daniel López, Rocío Liébana, Belen Rojas, José L. Gorrochategui, Julián|||0000-0001-9262-8716 Sanz, Miguel A.|||0000-0003-1489-1177 Ballesteros, Joan |
| author |
Bennett, Teresa A. |
| author_facet |
Bennett, Teresa A. Montesinos, Pau|||0000-0002-3275-5593 Moscardo, Federico Martinez-Cuadron, David Martinez, Joaquin Sierra, Jorge|||0000-0002-7966-0356 García, Raimundo Perez de Oteyza, Jaime|||0000-0002-8338-2037 Fernandez, Pascual Serrano, Josefina Fernandez, Angeles Herrera, Pilar|||0000-0002-4118-7110 Gonzalez, Ataulfo Bethancourt, Concepción Rodriguez-Macias, Gabriela Alonso, Arancha Vera, Juan A. Navas Elorza, Begona Lavilla, Esperanza|||0000-0003-1490-0678 López, Juan A. Jiménez, Santiago Simiele, Adriana Vidriales, Belen González, Bernardo J. Burgaleta, Carmen Hernández Rivas, José A. Córdoba Mascuñano, Raúl Bautista, Guiomar Perez Simon, José A. De la Fuente, Adolfo Rayón, Consolación Troconiz, Iñaki|||0000-0003-3700-8658 Janda, Álvaro Bosanquet, Andrew G. Hernández-Campo, Pilar Primo, Daniel López, Rocío Liébana, Belen Rojas, José L. Gorrochategui, Julián|||0000-0001-9262-8716 Sanz, Miguel A.|||0000-0003-1489-1177 Ballesteros, Joan |
| author_role |
author |
| author2 |
Montesinos, Pau|||0000-0002-3275-5593 Moscardo, Federico Martinez-Cuadron, David Martinez, Joaquin Sierra, Jorge|||0000-0002-7966-0356 García, Raimundo Perez de Oteyza, Jaime|||0000-0002-8338-2037 Fernandez, Pascual Serrano, Josefina Fernandez, Angeles Herrera, Pilar|||0000-0002-4118-7110 Gonzalez, Ataulfo Bethancourt, Concepción Rodriguez-Macias, Gabriela Alonso, Arancha Vera, Juan A. Navas Elorza, Begona Lavilla, Esperanza|||0000-0003-1490-0678 López, Juan A. Jiménez, Santiago Simiele, Adriana Vidriales, Belen González, Bernardo J. Burgaleta, Carmen Hernández Rivas, José A. Córdoba Mascuñano, Raúl Bautista, Guiomar Perez Simon, José A. De la Fuente, Adolfo Rayón, Consolación Troconiz, Iñaki|||0000-0003-3700-8658 Janda, Álvaro Bosanquet, Andrew G. Hernández-Campo, Pilar Primo, Daniel López, Rocío Liébana, Belen Rojas, José L. Gorrochategui, Julián|||0000-0001-9262-8716 Sanz, Miguel A.|||0000-0003-1489-1177 Ballesteros, Joan |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Universitat Autònoma de Barcelona. Departament de Medicina |
| dc.subject.none.fl_str_mv |
Chemosensitivity Ex vivo Flow cytometry Individualized tumor response to testing Personalized medicine |
| topic |
Chemosensitivity Ex vivo Flow cytometry Individualized tumor response to testing Personalized medicine |
| description |
Background We have evaluated the ex vivo pharmacology of single drugs and drug combinations in malignant cells of bone marrow samples from 125 patients with acute myeloid leukemia using a novel automated flow cytometry-based platform (ExviTech). We have improved previous ex vivo drug testing with 4 innovations: identifying individual leukemic cells, using intact whole blood during the incubation, using an automated platform that escalates reliably data, and performing analyses pharmacodynamic population models. Patients and Methods Samples were sent from 24 hospitals to a central laboratory and incubated for 48 hours in whole blood, after which drug activity was measured in terms of depletion of leukemic cells. Results The sensitivity of single drugs is assessed for standard efficacy (E) and potency (EC) variables, ranked as percentiles within the population. The sensitivity of drug-combination treatments is assessed for the synergism achieved in each patient sample. We found a large variability among patient samples in the dose-response curves to a single drug or combination treatment. Conclusion We hypothesize that the use of the individual patient ex vivo pharmacological profiles may help to guide a personalized treatment selection. © 2014 The Authors. Published by Elsevier Inc. All rights reserved. |
| publishDate |
2014 |
| dc.date.none.fl_str_mv |
2 2014-01-01 2014 2014-01-01 |
| dc.type.none.fl_str_mv |
Article http://purl.org/coar/resource_type/c_6501 VoR http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.openaire.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
https://ddd.uab.cat/record/301838 https://dx.doi.org/urn:doi:10.1016/j.clml.2013.11.006 |
| url |
https://ddd.uab.cat/record/301838 https://dx.doi.org/urn:doi:10.1016/j.clml.2013.11.006 |
| dc.language.none.fl_str_mv |
Inglés eng |
| language_invalid_str_mv |
Inglés |
| language |
eng |
| dc.rights.none.fl_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.openaire.fl_str_mv |
info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
open access http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Dipòsit Digital de Documents de la UAB instname:Universitat Autònoma de Barcelona |
| instname_str |
Universitat Autònoma de Barcelona |
| reponame_str |
Dipòsit Digital de Documents de la UAB |
| collection |
Dipòsit Digital de Documents de la UAB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869412623698624512 |
| score |
15,81155 |